Historical record - last NADAC effective date: 1/22/2014
Product Information
PACLITAXEL 30 MG/5 ML VIAL is a generic product labeled by Hospira Inc., priced at $2.1290 per ML under NDC 61703034209. Its NADAC has been published 5 times since Jan 22, 2014.
FDA first approved this application on May 8, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
6 mg/mL
Manufacturer
Hospira Inc.NDC
61703034209
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
1/22/2014
Active Ingredients
PACLITAXELApproval Type
Generic (ANDA)
FDA Application
ANDA076131FDA Approved
5/8/2002
TE Code
AP
On Market Since
3/1/2004
Pharmacological Classes
Price Statistics
The NADAC for PACLITAXEL 30 MG/5 ML VIAL has been published 5 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1290 per ML |
|---|---|
| All-time high | $2.1290 (Feb 19, 2014) |
| All-time low | $2.1290 (Jan 22, 2014) |
| Median price | $2.1290 |
| Average price | $2.1290 |
| Largest weekly change | 0.0% (Jan 29, 2014) |
| Weeks tracked | 5 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Feb 19, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PACLITAXEL 30 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PACLITAXEL 30 MG/5 ML VIAL, manufactured by Hospira Inc., is $2.1290 per ML (NDC 61703034209), effective Feb 19, 2014.
How has the price of PACLITAXEL 30 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for PACLITAXEL 30 MG/5 ML VIAL has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for PACLITAXEL 30 MG/5 ML VIAL?
Since Jan 22, 2014, the NADAC for PACLITAXEL 30 MG/5 ML VIAL has ranged from a low of $2.1290 (Jan 22, 2014) to a high of $2.1290 (Feb 19, 2014), with a median of $2.1290 per ML.
Are there cheaper alternatives to PACLITAXEL 30 MG/5 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PACLITAXEL 300 MG/50 ML VIAL, is $1.7700 per ML — about 17% below PACLITAXEL 30 MG/5 ML VIAL.
Who manufactures PACLITAXEL 30 MG/5 ML VIAL?
PACLITAXEL 30 MG/5 ML VIAL (NDC 61703034209) is labeled by Hospira Inc., and CMS classifies it as a generic product.